QBE Insurance Dips After 2026 Rally as August Results Approach

QBE Insurance Dips After 2026 Rally as August Results Approach

June 16, 2026

Sydney, June 16, 2026, 09:02 (AEST)

  • QBE Insurance Group finished the day at A$23.45, down A$0.61, or 2.54%. Shares remain ahead 19.04% in 2026.
  • Shares slipped after getting near this year’s A$24.60 high. Some profit-taking probably weighed.
  • QBE drops half-year numbers and dividend info on August 14, putting that release at the top of the calendar.

QBE Insurance Group Limited dropped 2.54% to A$23.45 in the latest ASX trade. That was against a broader gain for financials, with the ASX 200 financials up 1.2% early Monday, according to Market Index. Shares in QBE are still higher for the week and this year. Lower yields, softer oil, and some risk appetite pushed other financials up.

QBE shares gave back some gains after their recent rally, but the market hasn’t seen any new earnings warning. The stock is still trading close to its 2026 high. Valuation is tighter now, with QBE sitting at A$23.45 on Google Finance, while analysts’ 12-month target sits at A$24.41. That leaves about 4.09% potential upside, based on the average. QBE has a price-to-earnings ratio of 11.81. The P/E ratio gives a quick look at how the share price compares with its earnings per share.

QBE’s latest full-year results still give bulls something to lean on. Statutory net profit after tax landed at US$2.157 billion, while adjusted net profit after tax was US$2.132 billion. Gross written premium rose 7%. The group’s combined operating ratio was 91.9%. Gross written premium totals up all policy value before any deductions. The combined ratio, which measures claims and underwriting expenses as a share of premium income, points to underwriting profit when it stays below 100%.

QBE’s insurance profit can swing hard if weather hits, big claims land, prices slip or inflation rises. In its 1Q26 update, QBE showed about US$300 million in catastrophe costs so far for April, against its US$517 million first-half allowance. The company kept FY26 guidance unchanged, still forecasting mid-single-digit constant-currency premium growth and a combined operating ratio near 92.5%. Next time, the focus stays on premium growth, catastrophe costs, and whether underwriting margins hold.

QBE is looking fairly valued and a bit exposed to risk at these levels—shares aren’t cheap. The insurer has put up solid profit numbers, with returns and investment income backing that up, but the stock has already run in 2026 and trades near the average broker target now. Focus shifts to the August half-year result to see if there’s room to run, or if QBE stays open to profit-taking and disappointment if catastrophe claims or premium growth miss.

Mateusz Brzeziński

Mateusz Brzeziński is a financial and technology journalist at Bez-kabli.pl, covering stocks, artificial intelligence, semiconductors and global market developments. He graduated from the Prague University of Economics and Business in the Czech Republic and previously worked in financial analysis before moving into business journalism. His reporting focuses on the companies, technologies and market trends shaping the global economy.

Stock Market Today

  • ResMed (ASX: RMD) and TechnologyOne (ASX: TNE) called out for long-term value with $5,000 to invest
    July 9, 2026, 7:33 PM EDT. If you're putting $5,000 to work, ResMed Inc. (ASX: RMD) and TechnologyOne Ltd (ASX: TNE) are getting attention for long-term growth. ResMed, which makes products for sleep and breathing issues, is targeting an expanding healthcare segment where it saw revenue up 11% to US$1.4 billion in Q3 FY26. TechnologyOne, selling enterprise software into public and private sectors, posted 17% growth in annual recurring revenue to $598 million for H1 FY26. Both names rely on recurring revenue and spend on innovation, including artificial intelligence. These companies still face risks, but their steady demand and close customer ties may fit investors looking for sustainable value in the years ahead.